Wegovy (semaglutide) is a once-weekly injection that helps you lose weight by mimicking a natural hormone that regulates appetite. It's clinically proven to help you lose weight and improve your health, alongside a reduced calorie diet and increased physical activity.
Wegovy® Weight Loss Injections
(semaglutide)
Clinically proven to help you lose weight and improve your health, alongside a reduced calorie diet and increased physical activity.
- 4 weekly doses
- Includes clinical review
- Cold-chain delivery
-
UK registered cliniciansCare from qualified professionals
-
Fast, tracked deliveryDiscreet and reliable
-
Ongoing supportHere when you need us
-
Sharps bin includedSafe and convenient
New to Wegovy
Complete your eligibility assessment to see if Wegovy is right for you.
Start assessmentAlready taking Wegovy
Switch using evidence of your current prescription and dose.
Switch to Happy PharmacyExcellent on Trustpilot
Clinically reviewed facts
-
Active ingredientSemaglutide
-
Weekly injectionOnce a week
-
Strengths0.25 mg – 2.4 mg, up to 7.2 mg if eligible
-
UK clinician reviewPrescribed if suitable
Your treatment, supported from day one
A simple, secure process with expert care at every step.
-
1
Complete your assessment
Tell us about your health, goals and lifestyle. It only takes a few minutes and is completely confidential.
-
2
Clinician reviews your details
A UK-registered clinician will review your assessment and recommend the right treatment for you.
-
3
Delivered discreetly
Once approved, your medication is sent in discreet packaging, with ongoing support whenever you need it.
How Wegovy works
Wegovy (semaglutide) helps to reduce appetite and increase feelings of fullness, and Happy Pharmacy provides ongoing support to help you build healthier routines for the long term.
-
Reduces appetite
Helps you feel less hungry and eat less.
-
Increases fullness
Helps you feel fuller for longer so you're less likely to snack between meals.
-
Supports healthier habits
Our clinical team and resources help you build sustainable routines.
Wegovy doses at a glance
Prescribed gradually according to your response and clinical review.
Wegovy key points
- Treatment normally starts at 0.25 mg
- One injection, once weekly
- Four weekly doses in every FlexTouch pen
- Dose increases only following clinical review
Wegovy dose schedule
Most people start on 0.25 mg and may increase the dose every 4 weeks, subject to clinical review.
- 0.25 mg Weeks 1–4Start
- 0.5 mg Weeks 5–8
- 1 mg Weeks 9–12
- 1.7 mg Weeks 13–16
- 2.4 mg Week 17+Maintenance
- 7.2 mg After 4+ weeks on 2.4 mgIf eligible
Your clinician will only increase your dose when appropriate. Not everyone needs the highest dose.
Your weight loss journey.
All in one place.
Manage your treatment, track your progress and see your Happy Rewards in the Happy Pharmacy app.
- Manage your treatment
- Track your progress
- View your rewards
Important safety information
-
Who may be suitable
Wegovy is for adults with a BMI of 30+ or 27+ with weight-related health conditions. A clinical assessment is required to confirm suitability.
-
Common side effects
Nausea, vomiting, diarrhoea, constipation and stomach upset are common, especially when starting treatment. These usually improve over time.
-
When to seek help
Seek urgent medical advice if you have severe or persistent stomach pain, signs of dehydration, or symptoms of pancreatitis (such as severe abdominal pain).
Why Wegovy®
Benefits you need to know about
Beyond weight loss, Wegovy® has benefits that set it apart from other treatments — highlighted from the latest clinical evidence.
To explore how calorie intake and treatment may affect your projected timeline, use our Wegovy weight loss calculator. It provides a general estimate and cannot predict your individual result.
Protects your heart — independently of weight lost
In the SELECT trial, Wegovy® reduced the risk of major cardiovascular events by 20% relative risk reduction — independent of the amount of weight lost. Wegovy® is the only weight management medicine with a cardiovascular risk reduction indication.
Preserves muscle mass — 84.5% of weight lost is fat
MRI analysis from the STEP UP trial confirmed that 84.5% of weight lost was body fat, not lean muscle. Functional muscle capacity (measured by sit-to-stand test) was fully preserved vs placebo.
No need to change your contraceptive pill
Unlike some other weight loss medications, Wegovy® is not anticipated to reduce the effectiveness of oral contraceptives. No requirement to switch from pill to another contraceptive method.
Clinically meaningful knee pain relief
Wegovy® is the only approved pharmacotherapy to demonstrate a clinically meaningful improvement in knee osteoarthritis-related pain alongside superior weight loss vs placebo over 68 weeks.
Once a week, any time of day
Wegovy® is injected once weekly, with or without food, at any time of day. The 0.25–2.4 mg FlexTouch® pens contain four weekly doses. The 7.2 mg pack contains four single-use pens, one for each week.
Trusted by over 40 million patients worldwide
More than 40.8 million people worldwide have been treated with semaglutide-containing therapies since 2018. Wegovy® is manufactured by Novo Nordisk and supplied as a genuine, regulated medicine.
MHRA-licensed in the UK
Wegovy® is licensed by the MHRA for weight management in adults with obesity or overweight and weight-related health conditions, and for cardiovascular risk reduction in adults with established CVD.
94% similar to your own GLP-1 hormone
Semaglutide shares 94% sequence similarity with human GLP-1 — the body's natural hormone for regulating appetite and calorie intake. Targets key areas of the brain to reduce hunger and increase fullness.
About the Medicine
What is Wegovy® (semaglutide)?
Wegovy® is a prescription-only weight loss injection containing the active ingredient semaglutide. It is designed to support weight loss and long-term weight management in adults who meet specific clinical criteria.
Wegovy® is taken once weekly using a pre-filled injection pen and is prescribed alongside a reduced-calorie diet and increased physical activity. If you are preparing for your first injection, our guide to starting Wegovy explains what to expect during the first week and month. Wegovy belongs to a class of medicines known as GLP-1 receptor agonists (GLP-1 RAs), which mimic a naturally occurring hormone that regulates appetite and calorie intake.
You can buy Wegovy online from Happy Pharmacy following a consultation and prescriber approval. Your clinician will assess whether treatment is appropriate for your individual health profile. At Happy Pharmacy, Wegovy® is prescribed by qualified clinicians and dispensed by a UK GPhC-registered pharmacy. If you’d prefer not to use injections, you can also choose a once-daily Wegovy pill.
~21%
average body weight loss with 7.2 mg dose
40M+
patients treated with semaglutide worldwide
94%
similarity to your body's own GLP-1 hormone
20%
relative risk reduction in cardiovascular events
How does Wegovy work?
Semaglutide in Wegovy mimics the natural GLP-1 hormone. It acts on appetite-regulating areas of the brain to reduce hunger and help you feel fuller. It also delays stomach emptying, which can prolong fullness. Wegovy does not burn fat directly. It supports a lower calorie intake alongside dietary changes and physical activity, and individual responses vary as the dose is increased gradually.
Clinical Evidence
Clinically proven Wegovy® results
Wegovy® is backed by the STEP clinical trial programme — the largest weight management trial programme of its kind. Here is what the evidence shows.
What the latest clinical trial showed (2025)
In STEP UP, adults with obesity without diabetes taking Wegovy® 7.2 mg lost an average of 18.7% of their weight at 72 weeks in the overall analysis, compared with 3.9% on placebo. The continued-treatment analysis reported 20.7% versus 2.4%. These are trial averages, not individual forecasts. In the overall analysis, 90.7% lost at least 5% and 31.2% lost at least 25%. The 7.2 mg dose is an optional increase for eligible adults after at least four weeks on 2.4 mg, following prescriber review.
Standard dose results
At the usual maintenance dose of Wegovy® 2.4 mg, STEP 1 reported 14.9% average weight loss at 68 weeks, compared with 2.4% on placebo, alongside a reduced-calorie diet and increased physical activity. Our guide to Wegovy results and the weight-loss timeline explains the studies and why progress varies.
Treatment and results timeline
Dose timing may be adjusted by your prescriber. Trial averages do not predict an individual’s monthly weight loss. Treatment should be accompanied by a reduced-calorie diet and increased physical activity.
~21%
average weight loss in the continued-treatment analysis (STEP UP, 7.2 mg, 72 weeks)
>9/10
patients achieved ≥5% weight loss vs ~4/10 with placebo
1 in 3
patients achieved ≥25% weight loss vs 0% with placebo
20%
relative risk reduction in major cardiovascular events (SELECT trial)
| Treatment stage | Approximate timeframe | What this stage means |
|---|---|---|
| Initial dose (0.25 mg → 0.5 mg) | Weeks 1–8 | Starting treatment and assessing tolerability |
| Dose escalation (1 mg → 1.7 mg) | Weeks 9–16 | Gradual dose increases if tolerated |
| Maintenance dose (2.4 mg) | Weeks 17–68 | 14.9% average loss at week 68 in STEP 1; not a forecast for each week |
Heart Health
Wegovy® and cardiovascular risk reduction
Obesity is a major risk factor for cardiovascular disease (CVD), which affects over 7.6 million people in the UK. More than 2 in 3 patients with a high BMI die from CVD. For adults with established cardiovascular disease, the cardiovascular benefits of Wegovy are supported by the SELECT trial evidence below.
Body Composition
Preserving muscle while losing fat
A common concern with weight loss treatments is whether muscle mass is lost alongside fat. The STEP UP trial provides reassuring evidence. Read more about how to preserve muscle on Wegovy in our guide.
Wegovy® is the only weight management medicine with a cardiovascular risk reduction indication
In the SELECT trial — involving over 17,600 adults with overweight or obesity and established CVD, without diabetes — Wegovy® 2.4 mg reduced the risk of major adverse cardiovascular events by 20% relative risk reduction (1.5% absolute risk reduction) vs placebo, on top of standard of care.
SELECT trial: HR 0.80; 95% CI 0.72–0.90; p<0.001. All patients treated on top of standard of care including CV risk factor management and healthy lifestyle counselling.
20%
relative risk reduction in major cardiovascular events (SELECT trial)
Heart protection works regardless of weight lost
A prespecified analysis of the SELECT trial found that the cardiovascular benefit of Wegovy® was independent of the extent of weight loss — both patients who lost less than 5% and those who lost 5% or more experienced similar cardiovascular protection. This suggests potential mechanisms beyond weight loss alone.
MRI sub-study analysis from the STEP UP trial confirmed that when patients lost weight with Wegovy®, the vast majority of that loss came from body fat, not lean muscle. The small reduction in lean mass was not clinically significant.
Muscle function was assessed using a sit-to-stand test — there were no differences in functional muscle capacity between patients taking Wegovy® and those on placebo.
Am I Eligible?
Who is Wegovy® for?
Wegovy® is prescribed for adults who meet specific clinical criteria based on BMI and overall health. Eligibility is confirmed during your online consultation.
This list is not exhaustive. Final suitability is always confirmed following clinician review during your online consultation. Please refer to the Wegovy® SmPC for full prescribing information.
✓ You may be eligible if…
- BMI of 30 or above (clinically obese)
- BMI of 27 or above with a weight-related health condition (e.g. high blood pressure, high cholesterol, pre-diabetes, diet-controlled type 2 diabetes, sleep apnoea, or heart disease)
- Aged 18 or over
- Not pregnant or breast-feeding
- Able to follow dietary and lifestyle guidance
- Established cardiovascular disease (for CV risk reduction indication)
✗ Wegovy® may not be suitable if…
- You are pregnant, breast-feeding, or trying to conceive
- You have type 1 diabetes
- You are already taking another GLP-1 receptor agonist (e.g. Ozempic®, Mounjaro®)
- You have a history of pancreatitis
- You have a personal or family history of medullary thyroid carcinoma (MTC) or MEN2
- You have severe gastroparesis or severe gastrointestinal disease
- You have a known hypersensitivity to semaglutide or any of its excipients
Women's health
Please note: if you experience severe vomiting or diarrhoea while taking Wegovy®, this could theoretically affect the absorption of any orally taken medicine, including the pill. If this applies to you, follow the pill manufacturer's missed-dose guidance or seek advice from your prescriber or pharmacist.
Pregnancy: Semaglutide should not be used during pregnancy. If you wish to become pregnant, semaglutide must be stopped at least 2 months before a planned pregnancy due to its long half-life.
Breast-feeding: Wegovy® should not be used whilst breast-feeding.
Fertility: The effect of semaglutide on human fertility is currently unknown. Women of childbearing age are recommended to use contraception whilst taking semaglutide. For age-related considerations, see our guide to Wegovy for women over 40.
No need to change your contraceptive pill
Wegovy® does not affect how well the contraceptive pill works. You can continue taking your pill as normal — no switch to another form of contraception is needed. This is not the case with all weight loss injections.
Using Your Pen
How to use your Wegovy® pen
Wegovy® is injected once weekly on the same day, at any time, with or without food. Check which device you have: 0.25–2.4 mg FlexTouch® pens contain four doses; the 7.2 mg pen contains one dose and is used once. Read the leaflet supplied with your pen and ask your pharmacist or prescriber to explain anything you are unsure about.
FlexTouch® pens: 0.25 mg to 2.4 mg
1
Wash hands & prepare
Wash your hands thoroughly. Take your Wegovy® FlexTouch® pen from the fridge and allow it to warm slightly.
2
Attach a new needle
Attach a new needle for each injection and remove both needle caps. Check the flow before the first injection with each new pen, following the leaflet. Never reuse needles.
3
Choose your injection area
Inject into the abdomen (at least 5 cm from the navel), upper thigh, or upper arm (if someone else is injecting).
4
Rotate sites weekly
Always rotate injection sites and leave at least one finger-width between spots to avoid skin irritation.
5
Clean skin & check dose
Clean the skin with an alcohol wipe, allow to dry, and confirm the correct prescribed dose is selected on the pen.
6
Inject & hold
Press and hold the dose button until the counter shows 0. Keep the needle in your skin and count slowly to 6 before removing it, as shown in the leaflet.
7
Dispose safely
Remove the needle and place it immediately in your sharps container. Replace the pen cap.
8
Record your dose
Note the date and dose taken. Wegovy® is given once weekly — try to inject on the same day each week.
9
Store correctly
Store unused pens in the fridge (2–8°C). Once in use, the pen may be kept below 30°C for up to 6 weeks. Do not freeze. Read our guide on how to store Wegovy.
Wegovy® 7.2 mg single-use pens
A four-week pack contains four pens. Use one pen each week, then dispose of it safely in a sharps container. Each pen has a built-in needle and a preset dose, so you do not attach a needle or turn a dose selector. Follow the 7.2 mg patient leaflet and illustrated instructions: press the pen firmly against the skin and keep it in place until the yellow bar has stopped moving. Do not reuse the pen.
Store 7.2 mg pens in the fridge at 2–8°C, in their original carton to protect them from light. They may be kept unrefrigerated for up to 28 days at no more than 30°C. Discard a pen if it has been out of the fridge for more than 28 days, exposed to light or temperatures above 30°C, or frozen. The six-week in-use guidance above applies to FlexTouch® pens, not the 7.2 mg single-use device.
FlexTouch® pen recycling
Used FlexTouch® pens can be recycled through the Novo Nordisk PenCycle™ scheme — a free recycling programme to help reduce pharmaceutical waste. Read how to dispose of your Wegovy pen safely, including where detachable needles go and when PenCycle can be used.
Safety Information
Wegovy® side effects
Like all prescription medicines, Wegovy® can cause side effects — but most are mild to moderate and improve over time, particularly during dose escalation. This information does not replace the full SmPC or your prescriber's advice.
⚠ Very common side effects (≥1 in 10 patients)
- Nausea
- Vomiting
- Diarrhoea
- Constipation
- Abdominal pain
- Headache
- Fatigue
⚠ Common side effects (1–10 in 100 patients)
- Dizziness, dysgeusia (altered taste)
- Gastritis, indigestion, heartburn, bloating
- Hair loss
- Injection site reactions
- Gallstones (cholelithiasis)
- Hypoglycaemia (in patients with type 2 diabetes)
- Diabetic retinopathy (in patients with type 2 diabetes)
Serious / uncommon adverse reactions — seek urgent medical advice
For urgent symptoms, contact NHS 111. For emergencies (difficulty breathing, collapse), call 999. For the full list of adverse reactions, refer to the Wegovy® SmPC. Adverse events should be reported to the MHRA via the Yellow Card scheme or to Novo Nordisk on 0800 023 2573.
- Acute pancreatitis (uncommon): persistent, severe abdominal pain — stop treatment and seek urgent help
- Severe allergic reaction / anaphylaxis (rare): swelling of face, lips, throat, or difficulty breathing
- Kidney or bladder stones (uncommon)
- Hip fractures (rare): more common in women and those aged 75+
- NAION (very rare): sudden visual disturbance — seek urgent ophthalmology review
- Bowel obstruction (frequency unknown)
All Wegovy GuidesBrowse all Wegovy guides
Wegovy
WegovyCan Wegovy Help Menopause Weight Gain?
Read guide
WegovyCan You Drink Alcohol While Taking Wegovy?
Read guide
WegovyHow Long Can You Store Wegovy
Read guide
WegovyIs Wegovy Worth The Money ?
Read guide
WegovyMaintaining Weight Loss After Wegovy
Read guide
WegovyWegovy 7.2mg Explained
Read guide
WegovyWegovy and Muscle Preservation
Read guide
WegovyWegovy and PCOS
Read guide
WegovyWegovy Before and After Results
Read guide
WegovyWegovy Cost UK 2026
Read guide
WegovyWegovy Dose Schedule Guide
Read guide
WegovyWegovy for Women Over 40
Read guide
WegovyWegovy GPhC Pharmacy
Read guide
WegovyWegovy Side Effects Explained
Read guide
WegovyWegovy Tablets Dose Schedule
Read guide
WegovyWegovy Tolerance Guide
Read guide
WegovyWegovy Weight Loss Plateau Guide
Read guide
WegovyWhat Happens If You Miss a Wegovy Injection Dose ?
Read guide
Patient information
Official resources for Wegovy use, safety, and guidance.
References
1. What Wegovy (semaglutide) is — official UK product information
• Summary of Product Characteristics (SmPC) – Wegovy (semaglutide) –
emc
• Patient Information Leaflet (PIL) – Wegovy (semaglutide) –
emc
2. How it’s used — manufacturer / official patient instructions
• Wegovy patient resources and pen-use support – Wegovy UK
3. Clinical effectiveness — weight loss outcomes from trials
• STEP 1 Trial – Once-Weekly Semaglutide in Adults with Overweight or Obesity –
NEJM
• PubMed record (STEP 1 Trial) –
PubMed
• Review of the STEP clinical programme –
PMC
4. Cardiovascular benefits beyond weight loss — SELECT trial
• SELECT Trial – Semaglutide and Cardiovascular Outcomes in Obesity –
NEJM
• PubMed record (SELECT Trial) –
PubMed
• British Heart Foundation overview of Wegovy and heart health –
BHF
5. Eligibility and access decisions — UK guidance context
• NICE Technology Appraisal (TA875) – Semaglutide for managing overweight and obesity –
NICE
• NHS obesity treatment guidance –
NHS
• UK availability and rollout context –
Department of Health & Social Care
6. Safety and side effects — what to do and how to report
• Side effects, contraindications, warnings and precautions – SmPC (see section above) –
emc
• Yellow Card Scheme – report a side effect –
MHRA Yellow Card
Medically Reviewed for Clinical Accuracy
Authored by:
Palvinder DeolSuperintendent Pharmacist (MPharm, MRPharmS, GPhC Registered)
Over 25 years’ clinical experience in UK community pharmacy and medicines optimisation.
Reviewed by:
Nigel HowardIndependent Prescriber (MPharm, GPhC Registered)
Over 20 years’ clinical experience in prescribing and patient-facing pharmacy services.
GPhC Inspection Result
Inspection Outcome: All Standards Met ✅
Our digital-first pharmacy achieved rare “Good Practice” recognition during our GPhC inspection on 19 May 2025, showcasing our commitment to safe, high-quality and innovative online healthcare.
View full inspection report →GPhC Registration No. 9013192 | Inspected 19 May 2025
Frequently asked questions
Can you buy Wegovy online in the UK?
Yes, Wegovy is available to buy online in the UK through registered pharmacies following an online consultation. A prescriber will assess your medical history, BMI, and suitability before approving treatment.
How much does Wegovy cost per month in the UK?
The cost of Wegovy depends on the prescribed dose and whether you choose a subscription or single purchase. Use the dose selector at the top of this page for current prices. For more detail, read our guide to Wegovy costs in the UK.
Why does the price increase at higher doses?
Higher doses contain more medication, which increases the cost of each pen. As treatment progresses, doses are gradually increased to improve effectiveness.
Do I need to pay for a consultation?
Most online pharmacies include the consultation as part of the treatment cost. We are pleased to offer your consultation free of charge at Happy Pharmacy.
How often do I need to reorder Wegovy?
Each pack provides four weeks of treatment: one four-dose FlexTouch pen for 0.25–2.4 mg, or four single-use pens for 7.2 mg. Request your repeat supply before you run out, allowing time for prescriber review and delivery. If you have taken a treatment break, contact the clinical team before restarting.
Can I stay on a lower dose of Wegovy to reduce cost?
Some patients remain on lower doses if they are achieving good results. However, dose adjustments should always be guided by your prescriber.
Is it safe to buy Wegovy online in the UK?
Yes, if you use a GPhC-registered pharmacy like Happy Pharmacy with qualified prescribers. Avoid unregulated websites or suppliers.
Do I need a prescription for Wegovy?
Yes, Wegovy is a prescription-only medication in the UK.
Is Wegovy available on the NHS?
Wegovy is available on the NHS for some patients who meet strict eligibility criteria, but access is limited. Read our guide to NHS weight loss injection eligibility for the current routes and criteria.
Can I get Wegovy without seeing a GP?
You do not need to visit your GP in person. Online pharmacies provide consultations reviewed by UK prescribers.
What is Wegovy® used for?
Wegovy® is primarily used to support weight loss in individuals with obesity or overweight who have related medical conditions. It works by mimicking hormones that regulate appetite, helping to reduce hunger and calorie intake.
How does Wegovy work?
Wegovy contains semaglutide, which mimics the GLP-1 hormone to reduce appetite, slow digestion, and help you feel fuller for longer.
Is Wegovy approved for weight loss in the UK?
Yes, Wegovy is licensed by the MHRA for weight management in adults with obesity or overweight with related health conditions.
How much weight can you lose with Wegovy?
Clinical trials show patients can lose around 10–15% of their body weight on average when combined with diet and lifestyle changes.
How long does Wegovy take to work?
Many people notice appetite changes within the first few weeks, with more consistent weight loss developing over several months.
How long do you take Wegovy for weight loss?
Wegovy is designed for long-term use. Many patients continue treatment for several months or longer depending on results and clinical advice.
How long can you stay on Wegovy?
There is no fixed duration. Treatment continues as long as it remains effective and well tolerated under medical supervision.
Is weight loss with Wegovy gradual?
Yes, weight loss is typically gradual and progressive, especially as doses increase over time.
What affects how much weight you lose?
Results depend on factors such as:
- Starting weight
- Dose
- Diet and lifestyle
- Consistency with injections
- Individual metabolism
Why am I not losing weight on Wegovy?
Weight loss may slow or plateau due to factors like calorie intake, dose level, or metabolic adaptation. Your prescriber may adjust your plan.
What happens if you stop taking Wegovy?
Appetite may increase and some weight regain can occur if lifestyle changes are not maintained.
Can I switch from another treatment (e.g. Saxenda or Mounjaro)?
Switching to Wegovy after Mounjaro requires prescriber guidance. Your prescriber should agree the timing and starting dose after reviewing your final Mounjaro dose, side effects and other medicines. Do not overlap the treatments or choose the new dose yourself. Read our guide to switching from Mounjaro to Wegovy
Can weight loss plateau on Wegovy?
Yes, plateaus are common during weight loss. Adjusting diet, activity, or dose may help.
How long does Wegovy delivery take?
Orders are typically dispatched within one working day after prescriber approval and prescription. Delivery time then depends on the service and your location. Tracking is provided after dispatch. Check our delivery policy for current services and charges; delivery estimates are not guaranteed.
Is Wegovy delivered in temperature-controlled packaging?
Wegovy may arrive without ice packs. The current manufacturer information supports controlled shipment below 30°C for up to 48 hours. This limit applies to delivery, not to indefinite storage at room temperature.
Place your pens in the fridge at 2–8°C when they arrive and follow the instructions supplied. If delivery is delayed, your parcel seems unusually hot, or you suspect the temperature limits have been exceeded, contact our pharmacy team before using the medicine. Do not use a pen that has been frozen. Packaging may vary with conditions.
See the official product information for FlexTouch pens and 7.2 mg single-use pens.
How should I store Wegovy?
Store unused pens in the fridge (2–8°C). Do not freeze.
How long can Wegovy be out of the fridge?
0.25–2.4 mg FlexTouch pens: after first use, keep for up to six weeks below 30°C or, preferably, refrigerated at 2–8°C. Before first use, keep refrigerated.
7.2 mg single-use pens: may be kept unrefrigerated for up to 28 days at no more than 30°C, in the original carton to protect from light. Each pen is used once and discarded. Do not apply the six-week FlexTouch rule to this device.
Do not freeze either type. Follow the leaflet supplied with your pen and ask the pharmacy if you are unsure how it has been stored.
How long does one pen last?
A 0.25–2.4 mg FlexTouch pen contains four weekly doses and lasts four weeks when used as prescribed. A 7.2 mg single-use pen contains one weekly dose; a pack of four pens provides four weeks of treatment. Dispose of each 7.2 mg pen after use.
What side effects should I expect with Wegovy?
Common side effects include nausea, diarrhoea, constipation, and reduced appetite. These often improve over time. Read our Wegovy side effects guide for practical management advice and warning signs.
Can I drink alcohol while taking Wegovy?
Alcohol is not strictly prohibited, but it may worsen nausea or dehydration. Read our full guide to Wegovy and alcohol for practical advice.
What foods should I avoid on Wegovy?
Fatty, greasy, or very large meals may worsen side effects. Smaller, balanced meals are usually better tolerated.
Can you lose weight on Wegovy without exercise?
Yes, but combining treatment with physical activity improves results and overall health.
What if I miss a dose of Wegovy?
If your injection is no more than five days overdue, take the missed dose as soon as you remember, then continue on your usual weekly day. If more than five days have passed, skip it and take the next dose on your normal scheduled day. Never take a double dose to make up for a missed injection.
If you have missed more than one dose or had a treatment break, speak to your prescriber before restarting. A lower restart dose may be needed. Follow the FlexTouch leaflet or 7.2 mg leaflet supplied with your device.
Can I travel with Wegovy?
Yes. Keep Wegovy in your hand luggage, protect it from heat and freezing, and follow the storage guidance supplied with your pen. For airport security, storage and missed-dose planning, read our guide to travelling with Wegovy.
Can I use Wegovy during pregnancy?
No, Wegovy should not be used during pregnancy.
Can I use Wegovy while breastfeeding?
Wegovy is not recommended during breastfeeding.
Do I need to use contraception while taking Wegovy?
Yes, effective contraception is recommended during treatment.
Does Wegovy affect the contraceptive pill?
Semaglutide is not expected to reduce the effectiveness of the contraceptive pill. If you have vomiting or severe diarrhoea, follow the advice in your pill leaflet and contact your pharmacist or prescriber.
Who should not take Wegovy?
Wegovy may not be suitable for people with certain medical conditions. Always follow prescriber guidance.
Is Wegovy the same as Ozempic?
Both contain semaglutide, but Wegovy is specifically licensed for weight loss, while Ozempic is primarily for diabetes.
What’s the difference between Wegovy and Mounjaro?
Wegovy targets GLP-1 receptors, while Mounjaro targets both GLP-1 and GIP receptors, which may lead to different weight loss outcomes. Read our Mounjaro vs Wegovy comparison for a fuller review of effectiveness, dosing and suitability.
Are there alternatives to Wegovy?
Yes, alternatives include Mounjaro (tirzepatide) and Orlistat tablets
Is Wegovy a long-term solution?
Wegovy is designed to support long-term weight management when combined with lifestyle changes.
Does weight come back after stopping Wegovy?
Weight regain can occur if lifestyle habits are not maintained after stopping treatment.
Is Wegovy safe long-term?
Clinical studies support its safety when used under medical supervision.
Ready to start your journey?
Get expert support and a personalised treatment plan today.